• PCN129 - TREATMENT COSTS AND PROGRESSION-FREE SURVIVAL OF DVD AND KRD REGIMENS SEQUENCES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2018, 00:00

  • PRM256 - ADJUSTMENT FOR THE IMPACT OF SUBSEQUENT THERAPIES NOT AVAILABLE IN UK ON OVERALL SURVIVAL (OS) IN CASTOR TRIAL- A SUBGROUP ANALYSIS IN SECOND-LINE (2L) PATIENTS

    Oct 1, 2018, 00:00

  • PHP117 - TRENDS OF PRESCRIPTION FOR OFF-LABEL DRUGS IN KOREAN PEDIATRIC PATIENTS USING CLAIMS DATA- WITH A FOCUS ON CLINICAL AREAS AND PRIMARY DISEASES

    Oct 1, 2018, 00:00

  • PIN8 - COMPARATIVE EFFICACY OF FIDAXOMICIN, VANCOMYCIN AND METRONIDAZOLE FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PCN274 - TIME TO PRICE CHANGE FOLLOWING HTA DECISIONS

    Oct 1, 2018, 00:00

  • PMH60 - A COST-UTILITY ANALYSIS OF A MENTAL HEALTH PROMOTION PROGRAM IN SOCIAL ECONOMY COMPANIES IN FLANDERS

    Oct 1, 2018, 00:00

  • PMS63 - COST-EFFECTIVENESS OF ACTONEL® 35 MG (RISEDRONATE) GASTRO-RESISTANT TABLETS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN FRANCE

    Oct 1, 2018, 00:00

  • PHP206 - TUMOUR-AGNOSTIC AGENTS- ARE THEY FIT FOR REIMBURSEMENT?

    Oct 1, 2018, 00:00

  • PCV131 - IMPACT OF TIMELY INITIATION OF ANTIHYPERTENSIVE MEDICATIONS FOR PATIENTS WITH HYPERTENSION OR ELEVATED BLOOD PRESSURE

    Oct 1, 2018, 00:00

  • PCV53 - IS EDOXABAN MORE COST-EFFECTIVE THAN WARFARIN IN PREVENTION OF STROKE AND DEEP VEIN THROMBOSIS?

    Oct 1, 2018, 00:00

  • PCV35 - SECONDARY PREVENTION FOR CARDIOVASCULAR DISEASE- DEFINITION OF POPULATION AND EVALUATION OF OUTCOMES USING REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PSY114 - COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED WITH CONVENTIONAL THERAPY IN PATIENTS WITH CROHN’S DISEASE IN THE UNITED KINGDOM (UK)

    Oct 1, 2018, 00:00

  • PIN56 - COST-EFFECTIVENESS OF VARICELLA AND HERPES ZOSTER VACCINATION IN THE SWEDISH POPULATION

    Oct 1, 2018, 00:00

  • PSS13 - BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE

    Oct 1, 2018, 00:00

  • PND35 - HEALTHCARE, SICKNESS ABSENCE, AND DISABILITY PENSION COST TRAJECTORIES IN FIVE YEARS FOLLOWING MS DIAGNOSIS- REGISTER-BASED PROSPECTIVE COHORT STUDIES IN SWEDEN

    Oct 1, 2018, 00:00

  • PHP105 - A POPULATION-BASED DATA ANALYSIS OF DRUG PRESCRIPTION AND PATTERNS OF USE OF ANTIBIOTIC IN SOUTHERN ITALY POPULATION

    Oct 1, 2018, 00:00

  • PHP235 - INDIRECT TREATMENT COMPARISONS (ITC) FOR HTA IN EUROPE – UNDERSTANDING REQUIREMENTS FOR INDUSTRY SUBMISSIONS

    Oct 1, 2018, 00:00

  • PMH18 - MARKOV MODEL FOR PREDICTING THE RISK OF DEVELOPING DEMENTIA IN ELDERLY ADULTS

    Oct 1, 2018, 00:00

  • PSY143 - EPIDEMIOLOGY AND TREATMENT OF MICROSCOPIC COLITIS – REAL WORLD EVIDENCE FROM THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PND33 - PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS GLATIRAMER ACETATE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

    Oct 1, 2018, 00:00

  • PSY62 - DIRECT COST OFFSETS RELATED TO BELIMUMAB SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN SPAIN

    Oct 1, 2018, 00:00

  • PHP38 - ENZYME REPLACEMENT THERAPIES WITHIN THE GERMAN HTA (AMNOG) PROCESS

    Oct 1, 2018, 00:00

  • PCN223 - WHAT UNDERLIES THE OBSERVED HOSPITAL VOLUME-OUTCOME RELATIONSHIP?

    Oct 1, 2018, 00:00

  • PIN90 - RECENT TRENDS IN MENINGOCOCCAL DISEASE-RELATED INPATIENT CARE IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS

    Oct 1, 2018, 00:00

  • PCN123 - EVALUATION OF DRUG THERAPY COSTS FOR PATIENTS WITH BREAST CANCER, MELANOMA AND RENAL CELL CARCINOMA IN MOSCOW IN 2016-2017

    Oct 1, 2018, 00:00

  • PCV107 - MULTI-CRITERIA DECISION ANALYSIS (MCDA) - DISCUSSION ABOUT THE INCORPORATION OF RIOCIGUAT IN THE TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) UNDER THE PERSPECTIVE OF BRAZILIAN PUBLIC HEALTHCARE SYSTEM (SUS)

    Oct 1, 2018, 00:00

  • PUK28 - ASSESSMENT OF CHALLENGES ASSOCIATED WITH DRUG INNOVATION IN ORPHAN RENAL DISEASE

    Oct 1, 2018, 00:00

  • PCN227 - ACCESS TO ESSENTIAL ANTINEOPLASTICS AND IMMUNOSUPPRESSIVES

    Oct 1, 2018, 00:00

  • PCN99 - EVALUATING THE INCREASING STRAIN OF IMMUNOTHERAPIES (PD-1/PD-L1) ON PUBLIC HEALTHCARE SYSTEMS IN T5 + US

    Oct 1, 2018, 00:00

  • QL1 - VALIDATION OF PROMIS PREFERENCE SCORE (PROPR) IN GERMAN PATIENTS WITH RHEUMATOLOGICAL CONDITIONS

    Oct 1, 2018, 00:00

  • PSY97 - COST-EFFECTIVENESS ANALYSIS OF ENZYME REPLACEMENT THERAPY FOR TYPE 1 GAUCHER DISEASE

    Oct 1, 2018, 00:00

  • PMU1 - FREQUENCY OF REPORTABLE ADVERSE EVENTS IN HEALTH-RELATED SOCIAL MEDIA POSTS

    Oct 1, 2018, 00:00

  • PMU15 - ANALYSIS OF THE METHODOLOGICAL OBJECTIONS REGARDING INDIRECT TREATMENT COMPARISON SUBMITTED TO THE HAUTE AUTORITÉ DE SANTÉ (HAS)

    Oct 1, 2018, 00:00

  • PRS49 - COST-EFFECTIVENESS OF THE FIXED-DOSE COMBINATION TIOTROPIUM + OLODATEROL VERSUS TIOTROPIUM BASED ON THE DYNAGITO TRIAL RESULTS IN FRANCE

    Oct 1, 2018, 00:00

  • PMH23 - REAL-WORLD COSTS AND BUDGET IMPACT OF LONG-ACTING INJECTION ATYPICAL ANTIPSYCHOTICS FOR THE MANAGEMENT OF SCHIZOPHRENIA IN FRANCE

    Oct 1, 2018, 00:00

  • PUK36 - COMPARISON OF PATIENT-REPORTED OUTCOMES IN RANDOMIZED CONTROLLED TRIALS AND IN OBSERVATIONAL STUDIES FOR OVERACTIVE BLADDER- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMD100 - ECONOMIC EVALUATION OF PROTHROMBIN TIME TEST STRIPS (COAGUCHEK PRO II)

    Oct 1, 2018, 00:00

  • AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS

    Oct 1, 2018, 00:00

  • PMU9 - PALLIATIVE CARE IN GERMANY- AN EPIDEMIOLOGICAL STUDY BASED ON REAL WORLD DATA

    Oct 1, 2018, 00:00

  • PMS14 - CHILDHOOD OBESITY AND FRACTURE RISK- A REGION-WIDE LONGITUDINAL COHORT STUDY OF 466,000 CHILDREN AND UP TO 11 YEARS OF FOLLOW-UP

    Oct 1, 2018, 00:00

  • PMD173 - TREATMENT DIFFERENCES IN CHILDREN BURN CARE IN GERMANY BETWEEN BURN CENTERS AND NON-CENTERS

    Oct 1, 2018, 00:00

  • PCP70 - REGENERATIVE MEDICINE- A PROPOSED CLASSIFICATION FOR HEOR BASED ON THERAPEUTIC STRATEGY AND TECHNOLOGY TYPE

    Oct 1, 2018, 00:00

  • PMH71 - AN ASSESSMENT OF HEALTH OUTCOMES BY PATIENT ACTIVATION LEVEL IN THE EU5

    Oct 1, 2018, 00:00

  • PCV92 - EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES IN THE AORTIC POSITION IN ELDERLY PATIENTS

    Oct 1, 2018, 00:00

  • PCN344 - NUTRITION BEHAVIOUR OF PATIENTS WITH BREAST CANCER

    Oct 1, 2018, 00:00

  • PIN97 - VALIDATING DATA ON HEPATITIS C TESTING IN THE UK IN THE PRIMARY CARE SETTING

    Oct 1, 2018, 00:00

  • PSY179 - IMPACT ANALYSIS OF THE PHARMACEUTICAL COVERAGE EXPANDING POLICY FOCUSED ON ANTICANCER RARE DISEASE IN KOREA

    Oct 1, 2018, 00:00

  • PMH20 - BUDGETARY IMPACT OF TREATING OPIOID ADDICTION IN THE DANISH MUNICIPAL SETTING

    Oct 1, 2018, 00:00

  • PGI7 - ROBUST ESTIMATES CONCERNING THE HCV ELIMINATION STRATEGY IN GREECE. COMBINING THE RESULTS FROM TWO DIFFERENT MATHEMATICAL MODELS

    Oct 1, 2018, 00:00

  • PDB111 - TREND AND FACTORS ASSOCIATED WITH PREVENTABLE HOSPITALIZATION AMONG DIABETES MELLITUS PATIENTS IN A NATIONAL HEALTH INSURANCE PROGRAM

    Oct 1, 2018, 00:00

  • PHP85 - THE RISE OF THE NON-SUBMISSION – A WORRYING TREND FOR UK PATIENT ACCESS WITH ‘BREXIT’ APPROACHING

    Oct 1, 2018, 00:00

  • PHP237 - OVERVIEW OF GERMAN AMNOG DOSSIERS WITH PRICE ANALYSIS BEFORE AND AFTER EARLY BENEFIT ASSESSMENT

    Oct 1, 2018, 00:00

  • PCV4 - NON CARDIOVASCULAR COMORBITY AND PROGNOSIS OF CONGESTIVE HEART FAILURE

    Oct 1, 2018, 00:00

  • PDB67 - ONCE-WEEKLY SEMAGLUTIDE VERSUS DULAGLUTIDE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES IN PORTUGAL- A LONG-TERM COST-EFFECTIVENESS ANALYSIS BASED ON SUSTAIN 7

    Oct 1, 2018, 00:00

  • PGI11 - HIGH LEVELS OF REIMBURSED COST AND USE OF GASTROENTEROLOGICAL DRUGS IN FRANCE

    Oct 1, 2018, 00:00

  • PMH11 - E-THERAPIES IN PREVENTING AND TREATING EATING DISORDERS- REVIEW OF TRIALS AND REAL-WORLD EVIDENCE

    Oct 1, 2018, 00:00

  • PRM191 - LONGITUDINAL CONSTRUCT VALIDITY OF THE HEMOPHILIA CAREGIVER IMPACT MEASURE

    Oct 1, 2018, 00:00

  • PUK3 - STUDY OF DIABETIC NEPHROPATHY PREVALENCE AMONG TYPE 2 DIABETIC OUTPATIENTS WITH UNCONTROLLED GLYCEMIA

    Oct 1, 2018, 00:00

  • PIN25 - PROJECTED BURDEN OF VACCINE-PREVENTABLE DISEASES IN OLDER ADULTS IN THE UNITED STATES- IMPACT OF POPULATION AGING

    Oct 1, 2018, 00:00

  • PRM217 - THE ONLINE VERSION OF EMPRO- A NEW PLATFORM SYSTEM FOR THE STANDARDIZED APPRAISAL OF PRO INSTRUMENTS.

    Oct 1, 2018, 00:00

  • PSY171 - EXPECTED AND ACTUAL REIMBURSEMENT BASED ON CLINICAL PRACTICE GUIDELINE RECOMMENDATIONS IN TURKEY

    Oct 1, 2018, 00:00

  • PRM129 - DECISION ANALYTIC MODELS TO INFORM ABOUT THE OPTIMAL MAMMOGRAPHY SCREENING INTERVALS- A SYSTEMATIC REVIEW.

    Oct 1, 2018, 00:00

  • PND92 - ACCESS AND REIMBURSEMENT FOR CURRENT AND EMERGING ALZHEIMER’S DISEASE-MODIFYING THERAPIES IN THE EU5

    Oct 1, 2018, 00:00

  • PRM170 - UTILIZING PATIENT COLLAGES IN QUALITATIVE INTERVIEWS TO FACILITATE DATA COLLECTION IN PATIENTS DIAGNOSED WITH ULCERATIVE COLITIS

    Oct 1, 2018, 00:00

  • PCN229 - COMPARISON OF SICKNESS BENEFIT AND SICK LEAVE DURATION IN ONCOLOGY ACROSS COUNTRIES

    Oct 1, 2018, 00:00

  • PRM255 - QUANTIFYING SYSTEMATIC ERROR IN UNANCHORED INDIRECT COMPARISONS- THE IN-SAMPLE METHOD

    Oct 1, 2018, 00:00

  • PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?

    Oct 1, 2018, 00:00

  • PRM5 - PROFILING OF DISEASE SYMPTOMS AND ADVERSE EVENTS- DOES SOCIAL MEDIA AUGMENT TRADITIONAL APPROACHES?

    Oct 1, 2018, 00:00

  • HT7 - A REVIEW OF EFFICIENCY OPINIONS OF FRENCH ‘HAUTE AUTORITE DE SANTE’ (HAS) IN THE ONCOLOGY FIELD

    Oct 1, 2018, 00:00

  • PCN217 - KEEPING UP WITH THE COMPARATORS- TRENDS IN TARGETED CANCER THERAPIES BECOMING RIGHT COMPARATORS FOR PAYERS

    Oct 1, 2018, 00:00

  • PND120 - TREATMENT DECISIONS ABOUT FIRST-LINE DISEASE-MODIFYING TREATMENTS (DMTS) IN RELAPSING REMITTING MULTIPLE SCLEROSIS- A SYSTEMATIC REVIEW OF PATIENT NEEDS AND PREFERENCES

    Oct 1, 2018, 00:00

  • PCV23 - TIME TO TREATMENT INTENSIFICATION IN NEW STATIN USERS

    Oct 1, 2018, 00:00

  • PCV20 - NUMBER NEEDED TO TREAT FOR ORAL ANTI-COAGULANTS VERSUS VKA IN STROKE PREVENTION IN ATRIAL FIBRILLATION

    Oct 1, 2018, 00:00

  • PCN53 - STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS

    Oct 1, 2018, 00:00

  • PIH12 - PHARMACOEPIDEMIOLOGY OF DRUGS IN PREGNANT WOMEN WITH EXTRAGENITAL PATHOLOGY

    Oct 1, 2018, 00:00

  • PHP240 - HEALTH TECHNOLOGY ASSESSMENTS OF BEVACIZUMAB BIOSIMILARS- COULD A DEMONSTRATION OF COST-EFFECTIVENESS CHANGE THE RECOMMENDATION FOR REIMBURSEMENT VERSUS THE ORIGINATOR?

    Oct 1, 2018, 00:00

  • PMD174 - IMPACT OF MEDICAL DEVICE REGULATION ON FUTURE HTA’S AND REIMBURSEMENT DECISIONS IN GERMANY, FRANCE AND SWITZERLAND – WHAT IS BLOOMING HERE?

    Oct 1, 2018, 00:00

  • PUK10 - ANALYZING HEALTH-ECONOMIC EFFECTS OF A RENAL PRE-TRANSPLANT PATIENT-STRATIFICATION TOOL AT AN EARLY STAGE OF PRODUCT DEVELOPMENT

    Oct 1, 2018, 00:00

  • PMH68 - TREATMENT DISRUPTION AMONG PATIENTS WITH PARKINSON’S DISEASE WITH PSYCHOSIS ENROLLED IN US CENTERS FOR MEDICARE SERVICES

    Oct 1, 2018, 00:00

  • PMU45 - ESTIMATING THE CLINICAL AND ECONOMIC BURDEN OF HYPERKALAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE OR HEART FAILURE

    Oct 1, 2018, 00:00

  • PDB14 - MOBILE APPS FOR MEDICATION ADHERENCE IN DIABETES

    Oct 1, 2018, 00:00

  • PHP273 - A REVIEW OF ISSUES AFFECTING THE EFFICIENCY OF DECISION MAKING IN THE NICE SINGLE TECHNOLOGY APPRAISAL PROCESS

    Oct 1, 2018, 00:00

  • PMS79 - PHYSIOTHERAPY UTILIZATION INDICES IN HOME CARE IN HUNGARY

    Oct 1, 2018, 00:00

  • PIN126 - THE QUALITY OF LIFE (QOL) LOSS ASSOCIATED WITH INVASIVE MENNINGOCOCCAL B DISEASE (MENB) IN GERMANY

    Oct 1, 2018, 00:00

  • PSY31 - COMPARISON OF THE ESTIMATED PREVALENCE OF DIAGNOSED HOMOCYSTINURIA AND PHENYLKETONURIA IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PMD85 - INDIRECT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF MINIMALLY INVASIVE ENDOVENOUS CYANOACRYLATE GLUE OCCLUSION, SURGICAL AND OTHER TREATMENT OPTIONS IN CHRONIC VENOUS INSUFFICIENCY

    Oct 1, 2018, 00:00

  • PRS53 - COST-UTILITY ANALYSIS OF SQ® HDM SLIT-TABLET IN PATIENTS WITH HOUSE DUST MITE ALLERGIC RHINITIS WITH OR WITHOUT ALLERGIC ASTHMA IN POLAND

    Oct 1, 2018, 00:00

  • PMD115 - THE DIAGNOSTIC METHODS AND COST OF LUNG CANCER IN GREECE

    Oct 1, 2018, 00:00

  • PCN390 - METASTATIC COLORECTAL CANCER (MCRC) - LITERATURE REVIEW ON QUALITY OF LIFE INSTRUMENTS

    Oct 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer

    Oct 1, 2018, 00:00

  • PRM37 - REPRODUCIBLE COST ANALYSIS MODELING AMONG DIFFERENT GEOGRAPHIC REGIONS- A CASE EXAMPLE OF DUAL-MOBILITY CUPS IN REVISION TOTAL HIP ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PSY213 - WHAT MATTERS TO INDIVIDUALS WITH SICKLE CELL DISEASE? PATIENT INPUT ON THE RELEVANT AND IMPORTANT SYMPTOMS AND IMPACTS OF THE CONDITION

    Oct 1, 2018, 00:00

  • PHP216 - HOW RESPONSIVE IS INDUSTRY TO VALUE BASED PROCUREMENT (VBP)?

    Oct 1, 2018, 00:00

  • PMU35 - COST COMPARISON OF COMPLEMENTARY AND ALTERNATIVE MEDICINE SPECIALIZED UNIT IN SUS

    Oct 1, 2018, 00:00

  • PMD170 - A RESEARCH ON HOSPITAL BASED-HEALTH TECHNOLOGY ASSESSMENT MODELS OF ACQUISITION OF MEDICAL DEVICES IN HOSPITALS- THE CASE OF TURKEY

    Oct 1, 2018, 00:00

  • PCN266 - A REAL-WORLD DATA STUDY REGARDING HOSPITAL RESOURCES USE AND COSTS ASSOCIATED WITH BLADDER CANCER IN SPAIN

    Oct 1, 2018, 00:00

  • PCP4 - DEVELOMENT OF A QUALITY MANAGEMENT SYSTEM FOR EUNETHTA AND THE PERMANENT EUROPEAN COLLABORATION ON HTA

    Oct 1, 2018, 00:00

  • PND132 - ECONOMIC BURDEN OF MIGRAINE IN BRAZIL- RESULTS FROM MY MIGRAINE VOICE SURVEY

    Oct 1, 2018, 00:00

  • PCN135 - DOES PATIENT SELECTION CRITERIA TRANSLATE INTO COST SAVINGS IN PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER CHEMOTHERAPY FAILURE IN SPAIN?

    Oct 1, 2018, 00:00

  • PHP278 - GUIDELINES IN GERMAN EARLY BENEFIT ASSESSMENT – WHICH GUIDELINES ARE CONSIDERED BY FEDERAL JOINT COMMITTEE FOR DETERMINING THE APPROPRIATE COMPARATOR?

    Oct 1, 2018, 00:00

  • PCP45 - THE ROLE OF CROSSOVER AND TREATMENT SWITCHING IN INDIRECT TREATMENT COMPARSON IN IMMUNO-ONCOLOGY

    Oct 1, 2018, 00:00

  • PMD140 - OUT-OF-POCKET PAYMENTS FOR MEDICAL DEVICES AND EQUITY IN HEALTHCARE FOR PATIENTS WITH PRIMARY LYMPHEDEMA IN FRANCE

    Oct 1, 2018, 00:00

  • PHP271 - THE GROWING IMPORTANCE OF DIGITAL CHANNELS IN FORMULARY DECISION MAKING IN THE US

    Oct 1, 2018, 00:00

  • PHP135 - CHANGES IN THE NUMBER OF DENTISTS IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PMD68 - A COST-CONSEQUENCE ANALYSIS OF ANACONDA VERSUS PROPOFOL AND MIDAZOLAM IN THE LONG-TERM SEDATION OF CRITICALLY-ILL SURGICAL PATIENTS FROM THE UK NHS PERSPECTIVE

    Oct 1, 2018, 00:00

  • PCN226 - BIOSIMILARS AND THE REGULATION OF ONCOLOGICAL PREPARATIONS IN GERMANY

    Oct 1, 2018, 00:00

  • PCN103 - PREDICTED TREATMENT COSTS AND SAVINGS PER PATIENT OF KANJINTI® (TRASTUZUMAB BIOSIMILAR) VS. SUBCUTANEOUS (SC) AND INTRAVENOUS (IV) HERCEPTIN® AND OTHER TRASTUZUMAB BIOSIMILARS IN ITALY

    Oct 1, 2018, 00:00

  • PMD81 - COST EFFECTIVENESS ANALYSIS OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND FOR REFRACTORY PAINFUL BONE METASTASES

    Oct 1, 2018, 00:00

  • PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRAPARIB COMPARED WITH ROUTINE SURVEILLANCE IN THE MAINTENANCE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN CANCER

    Oct 1, 2018, 00:00

  • PCN249 - CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) AND DRIVERS OF ANTIEMETIC PRESCRIBING- RESULTS OF A QUALITATIVE IN-PRACTICE STUDY OF CLINICIANS FROM VARIOUS SETTINGS

    Oct 1, 2018, 00:00

  • PDB52 - ANNUAL COST OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN TURKEY

    Oct 1, 2018, 00:00

  • PSS36 - PHARMACOECONOMIC EVALUATION OF PHARMACOLOGICAL TREATMENT OPTIONS FOR PATIENTS WITH MODERATELY-SEVERE AND SEVERE PSORIASIS WITH BASE THERAPY RESISTANCE

    Oct 1, 2018, 00:00

  • PCN84 - TOTAL COST OF CARE AND BUDGET IMPACT FOR PATIENTS WITH CLL TREATED WITH VENETOCLAX

    Oct 1, 2018, 00:00

  • PMS20 - BUDGET IMPACT OF INTRODUCING SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

    Oct 1, 2018, 00:00

  • PND110 - GENE THERAPY PRODUCTS – MARKET ACCESS SITUATION IN EU AND IN SLOVAKIA

    Oct 1, 2018, 00:00

  • PSS40 - COST-EFFECTIVENESS OF OCRIPLASMIN FOR THE TREATMENT OF VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE- A BELGIAN PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMD2 - STUDY OF STATINS EFFECTS ON COGNITIVE IMPAIRMENT AMONG OUTPATIENTS WITH TYPE 2 DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PCN44 - FIRST-LINE TREATMENT EFFICACY IN EGFR-POSITIVE NON-SMALL CELL LUNG CANCER- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • CN6 - COST-EFFECTIVENESS MODEL OF MIDOSTAURIN (MIDO) VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH NEWLY DIAGNOSED FLT3 MUTATION-POSITIVE (FLT3+) ACUTE MYELOID LEUKEMIA (AML)- A FRENCH PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMD175 - MARKET ENTRY OF NEW MEDICAL DEVICES IN GERMANY - OUTPATIENT SECTOR

    Oct 1, 2018, 00:00

  • PRM50 - IMPROVEMENT OF EFFICIENCY OF SEVERE ATOPIC ASTHMA TREATMENT

    Oct 1, 2018, 00:00

  • PDB87 - A COST-OF-CONTROL ANALYSIS- ONCE-WEEKLY SEMAGLUTIDE REDUCES COST OF REACHING TREATMENT TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN NORWAY

    Oct 1, 2018, 00:00

  • PDB62 - COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN IN JAPAN BASED ON RESULTS FROM THE SUBGROUP ANALYSIS OF ASIAN PATIENTS IN THE EMPA-REG OUTCOME TRIAL

    Oct 1, 2018, 00:00

  • PDB132 - TYPE 2 DIABETES TREATMENT PATHS AND PATIENT OUTCOMES IN RESPONSE TO REIMBURSEMENT POLICY CHANGE IN FINLAND

    Oct 1, 2018, 00:00

  • PDB29 - TYPE 2 DIABETES- DISCONTINUATION OF ANTIDIABETIC DRUG DISPENSING 8 YEARS AFTER STARTING TREATMENT- A NATIONWIDE COHORT STUDY USING THE FRENCH NATIONAL HEALTH DATA SYSTEM (SNDS)

    Oct 1, 2018, 00:00

  • PHP163 - THE FRENCH HEALTH ECONOMIC RESEARCH PROGRAM(PRME)- AN OVERVIEW SINCE ITS CREATION IN 2013

    Oct 1, 2018, 00:00

  • PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS - A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY

    Oct 1, 2018, 00:00

  • Editorial Board

    Sep 20, 2018, 13:52

  • An Economic Evaluation of Migalastat Versus ERT for the Treatment of Fabry Disease in Japan

    Sep 1, 2018, 00:00

  • The Effect of Alternative Therapy Interventions On The Quality of Life of Dementia Patients- Meta-Analyses

    Sep 1, 2018, 00:00

  • Systematic Literature Review of Cost-Effectiveness Evaluations in Japan

    Sep 1, 2018, 00:00

  • Assessment of Knowledge, Perception and Attitude of Antibiotics use and Resistance Among the Medical and Paramedical Undergraduate Students of Gandaki Medical College Nepal

    Sep 1, 2018, 00:00

  • The Impact of Risk-Sharing Agreements on Drug Reimbursement Decisions in South Korea

    Sep 1, 2018, 00:00

  • Cost Minimization Study between Intravenous Rituximab (R-IV) vs Subcutaneous Rituximab (R-SC) in Thai Patients with Diffused Large B-CELL Lymphoma (DLBCL)- A Simulation of Electronic Health Record (E-HR) and Evidence Synthesis

    Sep 1, 2018, 00:00

  • Current Situation, Causes, and Solutions to Drug Shortage in China—A Case Study of Jiangsu Province

    Sep 1, 2018, 00:00

  • A Locally Developed Quality of Life Measurement Scale for Family Caregivers of Patients with Advanced Cancers in Singapore

    Sep 1, 2018, 00:00

  • Perceptions of Self-Medication Practices And Awareness Regarding Its Complications- A Community –Based Study

    Sep 1, 2018, 00:00

  • Identify The Temporal Medication Pattern In The Hypertensive Patients Using Sequential Pattern Mining and Relate The Patterns To The Outcome and Cost

    Sep 1, 2018, 00:00

  • The Identification of Patient-Centric Value Drivers for Self-Paid Treatments in Asia

    Sep 1, 2018, 00:00

  • Accessibility and Equity of Current General Practitioner Distribution in China

    Sep 1, 2018, 00:00

  • Patient Preference Study on Treatments of Non Small Cell Lung Cancer in Western China

    Sep 1, 2018, 00:00

  • Medical Costs of Hypoglycemia in Type 1 and Type 2 Diabetes Patients Using Basal Insulin Analogues in China- Based on Medical Record Data

    Sep 1, 2018, 00:00

  • Health States Utility Values In Osteoporosis Using Time Trade-Off

    Sep 1, 2018, 00:00

  • Cross Cultural Study to Predict Academic Achievement of Malaysian and Thailand Pharmacy Students 2017

    Sep 1, 2018, 00:00

  • The Impact of Quality of Life on Costs of Chronic Kidney Disease in China’s Four Metropolises

    Sep 1, 2018, 00:00

  • Incorporating Adherence in Cost-Effectiveness Analyses of Interventions for Asthma Treatment- A Systematic Review

    Sep 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Elbasvir/Grazoprevir Versus Peginterferon Αlpha-2A in Combination with Ribavirin in Patients with Chronic Hepatitis C Genotype 1b Infection in China

    Sep 1, 2018, 00:00

  • Incidence of Hip Fratures and Post Fracture Treatment In Women With Postmenopausal Osteoporosis In Taiwan

    Sep 1, 2018, 00:00

  • Trends in Health Information Technology Use Among Older People in The United States, 2009-2016

    Sep 1, 2018, 00:00

  • Cost Effectiveness of a Novel Pre-Operative Skin Prep. Vs. Conventional Practi An Analysis to Aid Hospital Based Clinical Decision Making in India

    Sep 1, 2018, 00:00

  • Hta Outcomes for Orphan Drugs in Oncology- Comparison of France, Germany and England

    Sep 1, 2018, 00:00

  • An Overview of Systematic Reviews- Complementary Therapies for Cancer Patients

    Sep 1, 2018, 00:00

  • Inconsistency in Effectiveness Results in Pharmacoeconomic Models for Schizophrenia

    Sep 1, 2018, 00:00

  • The Closure of Taiwan’s Small Hospitals and Changes in Patterns of Inpatient Care, From 2003 to 2012

    Sep 1, 2018, 00:00

  • The Prevalence and Burden of Hypertension and Obesity Among Patients with Type 2 Diabetes in Urban China

    Sep 1, 2018, 00:00

  • Do People With Crohn's Disease Value Health States Differently Based on Experience?

    Sep 1, 2018, 00:00

  • A Cost Claims Database Study with Propensity Score Applications in Covariates Selection and Balancing

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous vs Intravenous Rituximab for the Treatment of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma in Singapore

    Sep 1, 2018, 00:00

  • Burden and Source Of Out-Of-Pocket Health Expenditures in India

    Sep 1, 2018, 00:00

  • Health Utility Scores in Patients With Type 2 Diabetes Mellitus in Indonesia

    Sep 1, 2018, 00:00

  • Factors of High Asthma Expenditure in China- An 1-Year Retrospective Study

    Sep 1, 2018, 00:00

  • Factors Associated with Effectiveness of Population-Based Colorectal Cancer Screening

    Sep 1, 2018, 00:00

  • Healthcare Resource Utilization and Economic Burden of Herpes Zoster in Japanese Patients with Immunocompromised Conditions- A Claims Database Cohort Study

    Sep 1, 2018, 00:00

  • Quality of Life of Various Hepatitis C Disease Stages in an Asian Middle Income Country- Data From Malaysia

    Sep 1, 2018, 00:00

  • Medical Expenditure for Lung Cancer Per Clinical Visit in China- A 10-Year Multicenter Retrospective Survey (2002-2011)

    Sep 1, 2018, 00:00

  • Cost Analysis of Anti-Cancer Therapy in Ten Cancers in Taiwan

    Sep 1, 2018, 00:00

  • The Health Economic Impact of Optimizing Post-Hospitalization Management For An Exacerbation in Copd Patients in China

    Sep 1, 2018, 00:00

  • Innovative Access Pathways for Digital Healthcare Solutions- Learnings From a European Analogue Analysis for Asian HTA Bodies

    Sep 1, 2018, 00:00

  • Adherence To Insulin In Singaporean Pediatric Type 1 Diabetes Patients And Its Association With Glycemic Control And Healthcare Utilization

    Sep 1, 2018, 00:00

  • Treatment Communication Between Patients With Serious Mental Illness (Smi) and Providers

    Sep 1, 2018, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsule (Original) Compared With Immediate-Release Phenytoin Capsule (Generic) for Epilepsy Patients in Thailand

    Sep 1, 2018, 00:00

  • Association Between Different Initial Date of Anti-Osteoporosis Medications With Subsequent Fracture-Related Hospitalization and Mortality- A Real-World Data Analyses 2008-2013

    Sep 1, 2018, 00:00

  • Smoking Trends in Japan From 2008-2017- Results From The National Health and Wellness Survey

    Sep 1, 2018, 00:00

  • Impact of Amnog on the Comparison of Orphan Drug Prices Between France and Germany

    Sep 1, 2018, 00:00

  • How Errors in the Implementation of Background Mortality Leads to Bias in Models

    Sep 1, 2018, 00:00

  • Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies- Challenges and Potential Solutions

    Sep 1, 2018, 00:00

  • Cross-National Comparison of Biosimilar Medicines - Market Penetration and Competition with Originators

    Sep 1, 2018, 00:00

  • How Much do Malaysians Value Dengue Vaccine? Evaluating the Willingness to Pay (WTP) for Hypothetical Dengue Vaccine with Two-Part Model (TPM)

    Sep 1, 2018, 00:00

  • An Analysis of Price and Access Timeline of Oncology Drugs Across Eu5 Countries

    Sep 1, 2018, 00:00

  • Methodological Quality of Drug Safety Systematic Reviews- A Cross-Sectional Study

    Sep 1, 2018, 00:00

  • Cost Analysis of Antibiotic Use in a Vietnamese Hospital

    Sep 1, 2018, 00:00

  • Dynamic Evaluation of Utilization of Innovative Oncology Drugs Under National Health Insurance System in Taiwan

    Sep 1, 2018, 00:00

  • The Impact of Glycemic Control on Cognition in People with Type 2 Diabetes

    Sep 1, 2018, 00:00

  • Health Care Utilization and Treatment Costs of the Patients with Hepatitis C Virus Infection in Zhengzhou, China

    Sep 1, 2018, 00:00

  • Orphan Drug Policy and Access Dynamics in Japan

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Problems- Treatment Cost of Dislocation and Sprain of Joints And Ligaments of Knee

    Sep 1, 2018, 00:00

  • Patient Involvement in Health Technology Assessments- An International Comparison

    Sep 1, 2018, 00:00

  • Economic Burden of Haze-Related Respiratory Illnesses in Selangor, Malaysia

    Sep 1, 2018, 00:00

  • Trends and Patterns of Antibiotic Consumption in China- Evidence From A 5 Year Surveillance in Shandong Province, 2012-2016

    Sep 1, 2018, 00:00

  • Value-Based Healthcare Delivery - A Success Story for Taiwan ?

    Sep 1, 2018, 00:00

  • A Comparison of Patient Characteristics Between Glp-1 Ra and Insulin Initiators in China

    Sep 1, 2018, 00:00

  • The Effect of a Schizophrenia Pay-For-Performance Program on Patient Outcomes–Propensity Score Matching with Difference-In-Differences Design

    Sep 1, 2018, 00:00

  • Cost-Analysis of Posaconazole for Prophylaxis Against Fungal Infections in Patients with Hematological Malignancies in Qatar

    Sep 1, 2018, 00:00

  • Expert Consensus in the Development of A Pediatric Patient-Reported Outcome Measure for Korean Medicine Treatment- A Delphi Study

    Sep 1, 2018, 00:00

  • Coverage Gap For Prescription Drugs Among Children in The Us- Evidence From the National Health Interview Survey

    Sep 1, 2018, 00:00

  • Direct-to-Patient Contact- A Cost Effective Study Design Alternative for South East Asian and Rare-Disease Affiliate Groups Interested in Generating Local Real-World-Evidence Health Outcomes Data

    Sep 1, 2018, 00:00

  • Age and Gender Differences in Self-Reported Physical, Functional, and Mental Health in Taiwan

    Sep 1, 2018, 00:00

  • Survival And Healthcare Utilization After Venous Thromboembolism In Taiwan, A Nationwide Study

    Sep 1, 2018, 00:00

  • Electronic Cigarettes and Intention To Smoke Cigarettes Among Adolescents in Taiwan

    Sep 1, 2018, 00:00

  • How Does G-BA Decision Impact Oncology Drug Prices in Germany?

    Sep 1, 2018, 00:00

  • Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015

    Sep 1, 2018, 00:00

  • The Impact of Pre-Authorization Policy in the use of Colistin Antibiotic at King Salman Military Hospital Saudi Arabia

    Sep 1, 2018, 00:00

  • Markov Model Calibration of Weibull Distributed Transition Probabilities Using Scientific Python Optimization Packages

    Sep 1, 2018, 00:00

  • Assessing Health-Related Quality of Life In Patients With Osteoporotic Vertebral Fractures- A Systematic and Standardized Comparison of Available Instruments Using The Empro Tool

    Sep 1, 2018, 00:00

  • A Pilot Study For Estimation Of Willingness-To-Pay Per Quality Adjusted Life Year (WTP PER QALY) as Cost Effectiveness Threshold in Indonesia

    Sep 1, 2018, 00:00

  • Are Time Trade-Off Values of Worse-Than-Death Health States Valid?

    Sep 1, 2018, 00:00

  • Are Orphan Drug Prices Fair?

    Sep 1, 2018, 00:00

  • A Study on Factors Influencing Drug Prices Among National Public Hospitals in the Philippines

    Sep 1, 2018, 00:00

  • Development of An Economic Model to Assess the Cost-Effectiveness of Proton Beam Therapy in Patients with Hepatocellular Carcinoma in Japan

    Sep 1, 2018, 00:00

  • Value-Based Health Care in Asia- Outcomes From Taiwan's Pay-For-Performance Programs

    Sep 1, 2018, 00:00

  • Analysis of Assisted Reproductive Technologies in Ukraine, Japan and Usa

    Sep 1, 2018, 00:00

  • Europe-China Comparison of Orphan Drugs Approvals

    Sep 1, 2018, 00:00

  • Financial Disclosure Statements

    Sep 1, 2018, 00:00

  • Disability Adjusted Life Years for Liver Cancer in China- Trend Analysis from 1990-2016 and Future Prediction

    Sep 1, 2018, 00:00

  • Modelling the Potential Impact of Pneumococcal Conjugate Vaccination in Thailand

    Sep 1, 2018, 00:00

  • Comparision of Child-Nursing Accident Sick-Pay and Accident Sick-Pay for Employees and Members of Individual and Corporate Enterprises in Hungary Between 2001-2016

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Immunotherapy Strategies for Advanced Melanoma in Taiwan

    Sep 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Randomized Trials of Surgery and Minimally Invasive Techniques Versus Cyanoacrylate Embolization for Varicose Veins

    Sep 1, 2018, 00:00

  • Healthcare Utilization of Patient with Breast Cancer Following Exposure to Telemedical Care

    Sep 1, 2018, 00:00

  • Urinary Tract Infections-Incidence in Patients with Type 2 Diabetes Mellitus

    Sep 1, 2018, 00:00

  • Consumer Willingness-To-Pay and Preference for Skin Cancer Screening Services in Australia

    Sep 1, 2018, 00:00

  • Systematic Review of Economic Evaluations and Decision Models on Brca1/2-Mutations Related Health Interventions

    Sep 1, 2018, 00:00

  • Evaluating the Efficacy of Vaccinating Pigs Against Gonadotropin Releasing Factor (Gnrf) with Regards to Asian Consumers' Attitudes

    Sep 1, 2018, 00:00

  • Patient-Reported Outcomes in Observational Studies for Overactive Bladder- A Systematic Literature Review

    Sep 1, 2018, 00:00

  • Using EORTC QLQ-BR53 to Assess Health-Related Quality of Life in Women Breast Cancers

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared To Other Biologics For The Treatment of Psoriatic Arthritis In Saudi Arabia

    Sep 1, 2018, 00:00

  • Comparing the Long-Term Impact on Healthcare Resources and Costs Due to Single-Piece Acrylic Intraocular Lens (IOL) Implantation During Cataract Surgery- A Cost-Consequence Analysis From Italian Healthcare System Perspective

    Sep 1, 2018, 00:00

  • Trends in Alcohol-Related Hospitalizations, Emergency Visits, Costs and Mortality in Singapore Between 2006 and 2016

    Sep 1, 2018, 00:00

  • Real World Health Insurance Cost of Femoral Neck Fracture In Hungary- A Nationwide Cost of Illness Study

    Sep 1, 2018, 00:00

  • Descriptive Analysis of Drug Expense for Anti-Vascular Endothelial Growth Factor Therapy in Taiwan

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of A Randomized Controlled Trial to Reduce Fear of Cancer Recurrence

    Sep 1, 2018, 00:00

  • Cost of Treatment Analysis- Drug Therapy of Patients with Colorectal Cancer in Moscow

    Sep 1, 2018, 00:00

  • Trends in Medication Utilization, Glycemic Control, Rates of Severe Hypoglycemia and Lower Limb Amputations Among Type 2 Diabetes Patients with Chronic Kidney Disease in Singapore from 2012 to 2017

    Sep 1, 2018, 00:00

  • Epidemiological Characteristics, Medical Cost and Healthcare Resource Utilization of Diabetes-Related Complications Among Chinese Patients with Type 2 Diabetes Mellitus

    Sep 1, 2018, 00:00

  • Think Big (Biosimilar Inclusion Guide) for Our Children

    Sep 1, 2018, 00:00

  • Real-World Prescription Patterns and Comorbidity Burdens Among Adults with Nonalcoholic Fatty Liver Disease

    Sep 1, 2018, 00:00

  • A Cost-Benefit Analysis of The Second Generation Cessation Services Payment Scheme in Taiwan From A Societal Viewpoint

    Sep 1, 2018, 00:00

  • Efficacy and Safety in Self-Prepared Nasal Saline Irrigation and Clinical Outcome in Patient With Allergic Rhinitis

    Sep 1, 2018, 00:00

  • The Impact of Generic Drug Entry on Market Shares and Prices of Brand-Name Drugs– Evidence from Chinese Pharmaceutical Market

    Sep 1, 2018, 00:00

  • Comparison of Baseline Characteristics and Hospital Utilization Rates Between Asian American and White American Patients with Multiple Sclerosis in Hawaii

    Sep 1, 2018, 00:00

  • Stratification of Dengue Induced Acute Kidney Injury by Using Conventional, Akin and Rifle Definitions- A Comparative Analysis

    Sep 1, 2018, 00:00

  • Effect of Pharmacist’s Intervention on the Cost of Clinical Pathway for Gastric Cancer Operation

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Screening a 5 Year Old Child for Hearing Loss Using Sound Scouts Compared with no Screening- A Decision Model Analysis

    Sep 1, 2018, 00:00

  • The Use of Simulation for Estimating Hospital Treatment Capacity in Dealing With Mass Casualty Incidents

    Sep 1, 2018, 00:00

  • Concept of Data Security and Outpatient Monitoring of General Health Status

    Sep 1, 2018, 00:00

  • Validation of Algorithms to Identify Acute Myocardial Infarction, Ischemic Stroke, and Hemorrhagic Stroke Cases from Japanese Claims Database

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Opportunistic Infections in Hiv-Infected Patients in Taiwan

    Sep 1, 2018, 00:00

  • HTA Analysis of Cochlear Implant - Health Technology Assessment in Slovak Healthcare Environment

    Sep 1, 2018, 00:00

  • Is The Oral Contraceptive Pill Rx to Otc Switch Cost-Effective?

    Sep 1, 2018, 00:00

  • Cost–Effectiveness of Remifentanil Versus Fentanyl in Adult Surgery Based on a Meta Analysis of Randomized Controlled Trials

    Sep 1, 2018, 00:00

  • Antidiabetic Drugs Prescription Spatial Variability

    Sep 1, 2018, 00:00

  • Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacological Treatment for Chronic Obstructive Pulmonary Disease

    Sep 1, 2018, 00:00

  • Cost- Effectiveness of Deep Molecular Response with First- Line Nilotinib vs. Imatinib in PH+ Chronic Myeloid Leukaemia Measured by Effectively Treated Patient- Years in Bulgaria

    Sep 1, 2018, 00:00

  • Orphan Drugs- Health Technology Assessment and Pricing in Europe

    Sep 1, 2018, 00:00

  • Cost-Minimisation Analysis of Subcutaneous Versus Intravenous Trastuzumab for the Treatment of Early Breast Cancer and Metastatic Breast Cancer in Singapore

    Sep 1, 2018, 00:00

  • Early Predictors of Clinical Response at 8 Weeks in Patients with First-Episode Schizophrenia Treated with Risperidone

    Sep 1, 2018, 00:00

  • The Effect of HIP Fat on Health- Based on the Correlation Analysis Between HIP Circumference and Quality of Life

    Sep 1, 2018, 00:00

  • Effect of Methicillin Resistance on total Medical Cost Among Inpatients with Staphylococcus Aureus

    Sep 1, 2018, 00:00

  • Value-Based Pricing in Singapore- Is it a Race to the Bottom?

    Sep 1, 2018, 00:00

  • Statin use and Early Onset Cataract：A Population Based Case Control Study

    Sep 1, 2018, 00:00

  • Increased Length of Stay- Identification of Predictors in Patients With Diabetic Foot Surgery

    Sep 1, 2018, 00:00

  • Systematic Analysis and Quality Evaluation of Pharmacoeconomics Researches on Traditional Chinese Medicines

    Sep 1, 2018, 00:00

  • A Cross Country Comparison of the Reimbursement Requirements in Endemic and Non-Endemic Settings- An Application to a Dengue Vaccine

    Sep 1, 2018, 00:00

  • Factor Dispensation and Expenditures in Hemophilia B Patients Switching from Standard Half-Life to Extended Half-Life Recombinant Factor IX Replacement Products- Real-World Analysis in Japan

    Sep 1, 2018, 00:00

  • Estimating Cost of Diabetes and its Complications in Indonesia, Vietnam and the Philippines using National Claims Databases

    Sep 1, 2018, 00:00

  • Effectiveness of A Short Training For Community Pharmacists To Improve Knowledge And Practice in Asthma Counselling – A Simulated Patient Method

    Sep 1, 2018, 00:00

  • Trends in Prevalence of Statin Use and Treatment Burden for Statin Users with Comorbidities in South Korea

    Sep 1, 2018, 00:00

  • Impact of Comorbid Substance Abuse on Healthcare Utilization And Costs In Patients with Bipolar I Disorder Treated With Atypical Antipsychotics

    Sep 1, 2018, 00:00

  • An Investigation of Minor Ailments Management By Elderly in Non-Urban Areas

    Sep 1, 2018, 00:00

  • HBA1C As A Risk Factor For Cardiovascular Disease in Type 2 Diabetes Mellitus- A Hospital-Based Study in Taiwan

    Sep 1, 2018, 00:00

  • Pharmacoeconomic Evaluation of Bariatric Surgery Program in Morbidly Obese Diabetes Mellitus Type Two Patients in Thailand

    Sep 1, 2018, 00:00

  • A 10- Year Global Epidemiological Forecast Of Atrial Fibrillation

    Sep 1, 2018, 00:00

  • The Place of Ehealth Interventions in the Management Pathway of Inflammatory Bowel Disease (Ibd) Patients- A Systematic Review

    Sep 1, 2018, 00:00

  • Health-Related Quality of Life in Japanese Patients with Prostate Cancer Using EQ-5D-5L and FACT-P- Comparisons According to Treatment Type

    Sep 1, 2018, 00:00

  • Economic Burden of Atrial Fibrillation in Japan

    Sep 1, 2018, 00:00

  • A Meta-Analysis of Randomized Controlled Trials Comparing Once-Weekly Semaglutide to Control Therapy for the Treatment of Type 2 Diabetes

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Vedolizumab for the Management of Moderate-To-Severe Ulcerative Colitis in Thailand

    Sep 1, 2018, 00:00

  • Medical Cost Estimation for Elderly Acute Myeloid Leukemia (Aml) Using Real World Data in Japan

    Sep 1, 2018, 00:00

  • Health Insurance Cost of Raynaud Syndrome In Hungary- A Nationwide Cost of Illness Study

    Sep 1, 2018, 00:00

  • On the Value of the Umbilical Cord Blood Supply

    Sep 1, 2018, 00:00

  • Comparison of Clinical Burden of Hcv Infection Between Asia and Europe- an Overview of Systematic Review

    Sep 1, 2018, 00:00

  • Direct Medical Costs Associated with Cardiovascular Diseases Among the HIV-Infected Patients in Taiwan- A Population-Based Study

    Sep 1, 2018, 00:00

  • Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia- Cost-Effectiveness Analysis

    Sep 1, 2018, 00:00

  • CORRECTION

    Sep 1, 2018, 00:00

  • Health Insurance Coverage and Statin Prescription Among Adults in The US

    Sep 1, 2018, 00:00

  • Factors Affecting the Convenience of Cancer Patients for Drug Clinical Trials in Turkey- Final Analysis of A Multicenter Study

    Sep 1, 2018, 00:00

  • Burden of Illness Associated with Influenza Virus Infection in Japan- A Literature Review

    Sep 1, 2018, 00:00

  • Quality-Adjusted Life-Years without Constant Proportionality

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Durvalumab after Chemoradiation in Stage III Non-Small Cell Lung Cancer (Nsclc)

    Sep 1, 2018, 00:00

  • Humanistic and Economic Burden of HCV Infection- An Overview of Systematic Review

    Sep 1, 2018, 00:00

  • Anxiety and Insomnia Among Elderly People in Chonburi, Thailand 2017

    Sep 1, 2018, 00:00

  • Common Errors Made in Analyzing Japanese Claims Databases and how to Avoid them

    Sep 1, 2018, 00:00

  • Willingness to Pay Per Quality-Adjusted Life in Taiwan

    Sep 1, 2018, 00:00

  • Budget Impact of Orbital Atherectomy Compared to Rotational Atherectomy in Patients with Severely Calcified Coronary Artery Lesions in Japan

    Sep 1, 2018, 00:00

  • Burden of Ischemic Heart Disease And Stroke And Impact of Lipid Control And Modifiable Risk Factors In China

    Sep 1, 2018, 00:00

  • The “Second Negotiation” Policy in Chinese Hospitals

    Sep 1, 2018, 00:00

  • The Interactions Between Underlying Risk Factors And Climate Changes In The Occurrence Of Acute Myocardial Infarction – A Nationalwide Study

    Sep 1, 2018, 00:00

  • Pharmacist Involvement with Elderly Patients with Polypharmacy to Decrease Medical Service Use- Experience in Taiwan

    Sep 1, 2018, 00:00

  • Evaluation of the Healthcare Costs and Utilization of Patients with Metastatic Breast Cancer

    Sep 1, 2018, 00:00

  • Health Insurance Burden of Sport Related Medical Conditions- Treatment Cost of The Injuries of Lower Leg

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective

    Sep 1, 2018, 00:00

  • Differences In ADL At Admission And Discharge For Stroke Patients

    Sep 1, 2018, 00:00

  • Cost-Utility Analysis of Colorectal Cancer Treatment in A Third Level Public Hospital in Mexico

    Sep 1, 2018, 00:00

  • Pharmacoeconomics Education in Schools of Pharmacy in Japan- A Questionnaire Survey

    Sep 1, 2018, 00:00

  • Development and Validatin of A Practical Protocol For Improving The Quality Of Care of Patients Encounter Osteoporotic Fracture

    Sep 1, 2018, 00:00

  • Hospital Cost Savings Associated with Flowable Gelatin Hemostat for Anterior Cervical Spine Surgery in Chinese Patients- A Real-World Retrospective Cohort Study

    Sep 1, 2018, 00:00

  • Studies on Economic Burden of Disease Using Real-World Healthcare Data in Japan- A Systematic Review

    Sep 1, 2018, 00:00

  • Adverse Drug Reaction Monitoring of Atypical Antipsychotics- Exploration and Establishment of Risk Factors

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of u sing an Innovative Gradually Reducing Femoral Radius Design Implant VS. A Class of Metal-Backed Implants for Patients Undergoing Total Knee Arthroplasty (TKA) Surgery from an Indian Societal Perspective

    Sep 1, 2018, 00:00

  • Economic Analysis of Urea-Excipient Drug-Coated Balloon Therapy for Treatment of Femoropopliteal Artery Disease in Japan

    Sep 1, 2018, 00:00

  • Value-Based Decisions for Off-Patent Pharmaceuticals in Developing Countries – A Pilot Study Using Multi-Criteria Decision Analysis for Tenders in Indonesia

    Sep 1, 2018, 00:00

  • Analysis of Anticoagulation Therapy In Patients With Pulmonary Embolism Among The Population With Urban Basic Health Insurance In China

    Sep 1, 2018, 00:00

  • The Economic Burden of Sickle Cell Disease in the United States

    Sep 1, 2018, 00:00

  • Local Inputs for A Societal Perspective- Estimating the Friction Period in Australia

    Sep 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infection in Japan

    Sep 1, 2018, 00:00

  • Differences in Postoperative Admission Days and Nursing Care Levels Depending on Type of Surgeries for Colon Cancer Patients

    Sep 1, 2018, 00:00

  • A Simulation Study of the Effect of Screening on Lung Cancer Mortality in Asia

    Sep 1, 2018, 00:00

  • Cost Per-Responder Analysis of Secukinumab Compared to Other Biologics for Treatment of Moderate to Severe Psoriasis Patients in Saudi Arabia

    Sep 1, 2018, 00:00

  • EQ-5D-5L Derived Population Norms for Health-Related Quality of Life for Hong Kong General Population

    Sep 1, 2018, 00:00

  • Reducing healthcare costs in antidepressant non-responders- does timing of antipsychotic augmentation matter?

    Sep 1, 2018, 00:00

  • Treatment patterns, health care resource utilization and costs in patients affected by schizophrenia in italy- findings from a retrospective administrative database analysis

    Sep 1, 2018, 00:00

  • Economic Impact of Delayed Access to Sofosbuvir-Based Regimen Under the Thai Universal Health Coverage (UHC)

    Sep 1, 2018, 00:00

  • Evolution of Hta System in Japan- Progress and Conservatism

    Sep 1, 2018, 00:00

  • Estimating Quality Of Life In Advanced Heart Failure- Can We Differentiate Excellent Expert Clinician Proxies?

    Sep 1, 2018, 00:00

  • Economic Impact of Pharmacy Resident's Interventions in Medical Intensive Care Unit of University Hospital in Thailand

    Sep 1, 2018, 00:00

  • How Useful are the Pharmacoeconomics Systematic Reviews for Decision Making on Anticancer Drugs? a Systematic Review of Methods, Gaps, and Quality

    Sep 1, 2018, 00:00

  • Cost Analysis of Changing A Model of Care and Employing General Practitioners within Residential Aged Care Facilities Based on A Prospective, Stepped-Wedge, Cluster Randomised Trial in an Australian Setting

    Sep 1, 2018, 00:00

  • A Study of Determinants of Hospitalizations in India

    Sep 1, 2018, 00:00

  • The Association of Quality of Primary Care and the Potentially Avoidable Emergency Department (Ed) Visit

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Down-Scheduling Triptans in Australia

    Sep 1, 2018, 00:00

  • Determinants of Unmet Needs and Impact on Ambulatory Health Care Expenditures

    Sep 1, 2018, 00:00

  • A Novel, Simple and Accurate Method to Map Quality-Of-Life Scores to Utility Values

    Sep 1, 2018, 00:00

  • Methods Used for the Applicability of Real-World Data Sources to Individual Patient Decision Making

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Of Internet-Delivered Cognitive Behaviour Therapy For Adolescents With Irritable Bowel Syndrome

    Sep 1, 2018, 00:00

  • Economic Burden of Needle-Stick Injury Among Healthcare Workers in China

    Sep 1, 2018, 00:00

  • 180-Day Mortality and Its Predictors In Women With Contralateral Hip Fracture After Femoral Neck Fracture

    Sep 1, 2018, 00:00

  • Adjunctive Atypical Antipsychotic (Aap) Choice Affects Healthcare Utilization in Major Depressive Disorder (Mdd)

    Sep 1, 2018, 00:00

  • From Per-Diem Payment to Case-Based Per-Episode Payment for Acute Mental Disorders in Guangzhou, China- A Propensity Score Matching and Difference-in-Differences Analysis Using Real World Data

    Sep 1, 2018, 00:00

  • Application of Real-World Evidence to Assess Outcomes After Surgical Treatment for Benign Prostatic Hyperplasia

    Sep 1, 2018, 00:00

  • Is the risk of developing depressive disorder following osteoarthritis and rheumatoid arthritis different?

    Sep 1, 2018, 00:00

  • Patient Complexity and Services Provided of Local Clinics in Taiwan- How Many of Them are “Primary Care” Providers?

    Sep 1, 2018, 00:00

  • Dabigatran vs. Warfarin for Treatment of Atrial Fibrillation

    Sep 1, 2018, 00:00

  • Fitting A Model of Dengue Transmission to Empirical Data- Example of Rayong Province in Thailand

    Sep 1, 2018, 00:00

  • Health Related Income Loss in India- Are Acute Health Conditions Expensive?

    Sep 1, 2018, 00:00

  • Rates of Patient-Reported Outcome Claims for Orphan Drugs Approved by the European Medicines Agency

    Sep 1, 2018, 00:00

  • Antibiotic use in a Clinical Department of a University Hospital in Vietnam

    Sep 1, 2018, 00:00

  • Health Economics of Orphan Drugs in Japan

    Sep 1, 2018, 00:00

  • Trends of Prescription Pattern in Pediatric Intensive Care Unit- an Observational Study

    Sep 1, 2018, 00:00

  • Assessing the Value of Next-Generation Sequencing Technologies- An Introduction

    Sep 1, 2018, 00:00

  • Patient-Reported Outcome Measures for Medical Devices in Asia- A Literature Review

    Sep 1, 2018, 00:00

  • Fluorodeoxyglucose Positron Emission Tomography with Computerised Tomography for Oncological Indications- A Pragmatic Approach to Guide Subsidy Decisions

    Sep 1, 2018, 00:00

  • Impact of Pharmacists' Assistance in Care of Asthma Patients in A Tertiary Care Hospital

    Sep 1, 2018, 00:00

  • Factors Impacting Direct Costs Of Chronic Kidney Disease Among Chinese Urban Patients In Pre-Dialysis Phase

    Sep 1, 2018, 00:00

  • Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Relapse/Refractory Mantle Cell Leukemia (Rrmcl) Patients in China

    Sep 1, 2018, 00:00

  • Evaluation of the Efficacy of Acupuncture on Vascular Dementia After Stroke in Taiwan

    Sep 1, 2018, 00:00

  • International Comparison of HTA Decisions for Oncology Products

    Sep 1, 2018, 00:00

  • A Systematic Review Of Tocotrienol In Human- Preliminary Findings On The Lipid-Lowering Effects

    Sep 1, 2018, 00:00

  • Preference-Based Health-Related Quality Of Life For Heart Disease Patients In Japan

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Same Day Surgery and Anesthesia in Thailand

    Sep 1, 2018, 00:00

  • The Burden of Illness in Duchenne Muscular Dystrophy - How Much Evidence is Available?

    Sep 1, 2018, 00:00

  • Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous Regimen for Breast Cancer Management in Hong Kong

    Sep 1, 2018, 00:00

  • Determinants of National Reimbursement for New Oncology Drugs- A Retrospective Analysis in Taiwan

    Sep 1, 2018, 00:00

  • The Impact of Pricing Policy on Short-Supplied Drugs in Shandong, China- Interrupted Time Series Study

    Sep 1, 2018, 00:00

  • Identification of Low Risk Stable Cardiovascular Patients and Patient Acceptance for Fast-Track Medication Refill (FTMR) Service

    Sep 1, 2018, 00:00

  • Sudden Cardiac Death After Revascularization in Patients with Coronary Artery Disease and Left Ventricular Dysfunction

    Sep 1, 2018, 00:00

  • Literature Review to Identify Utility Data For Patients With Fistulae and/Or Crohn's Disease

    Sep 1, 2018, 00:00

  • Treatment Patterns And Drug Adherence In Patients With Hypertension And Dyslipidemia- Korean HTN/DYS Outcomes Research Group

    Sep 1, 2018, 00:00

  • Budget Impact Analysis of Regorafenib in the Third-Line Treatment of Patients with Metastatic Colorectal Cancer

    Sep 1, 2018, 00:00

  • Direct Observation of Drug Counseling Activities in Community Pharmacies in Hue City, Vietnam

    Sep 1, 2018, 00:00

  • Comparative Assessment of Asthma Control Outcomes Among Pediatric Asthma Patients- Learnings From Database Studies in The U.S and South Korea

    Sep 1, 2018, 00:00

  • Pricing and Reimbursement Frameworks in China, Japan and South Korea with Focus on Key Reimbursement Drivers

    Sep 1, 2018, 00:00

  • Long-Term Efficacy Of Lower Intensity Statin Therapy In Chinese Acute Coronary Syndrome Patients

    Sep 1, 2018, 00:00

  • Development of a Prediction Model of Hemoglobin A1C Based On Statistical Machine Learning Using Clinical Data

    Sep 1, 2018, 00:00

  • Estimating the Willingness to Pay to Avoid the Impacts of Foodborne Illnesses- A Discrete Choice Experiment

    Sep 1, 2018, 00:00

  • The Comparative Analysis of Risk-Sharing Agreements in Korea, Australia, Taiwan Focusing on Operation

    Sep 1, 2018, 00:00

  • The Direct Cost of Smoking Attributable Medical Expenditures in Taiwan

    Sep 1, 2018, 00:00

  • A Cost-Outcome Study- A Real-World Investigation of Long-Term Inpatient Hospital Utilisation and Costs for a Retrospective Cohort of Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity Based Fund ...

    Sep 1, 2018, 00:00

  • Health-Related Quality of Life (HRQOL) in Adolescents with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Sep 1, 2018, 00:00

  • Cost-Minimization Analysis of Vercise DBS System for Parkinson’s Disease in Japan

    Sep 1, 2018, 00:00

  • Cost Effectiveness Analysis of Using a Novel Diagnostic Test in Gastric Cancer Screening Programs for Population at Intermediate and High Risk

    Sep 1, 2018, 00:00

  • Grey Correlation Analysis on The Total Health Expenditure Structure and Per Capita Medical Expenses in China

    Sep 1, 2018, 00:00

  • A Comparative Analysis of Key Trends of Pharmaceutical Market and Reimbursement in Ukraine and Poland

    Sep 1, 2018, 00:00

  • The Economic Impact of Switching to Trastuzumab Biosimilar for the Treatment of Metastatic Breast Cancer from a Chinese Payer Perspective

    Sep 1, 2018, 00:00

  • Efficacy and Safety of Eribulin Compared with Control Therapy in Patients with Locally Advanced or Metastatic Breast Cancer- A Meta-Analysis of Randomized Controlled Trials

    Sep 1, 2018, 00:00

  • Economic Impact of Hypoglycemia Among Type 2 Diabetes Mellitus in Taiwan

    Sep 1, 2018, 00:00

  • Application of Constrained Optimization Methods in Health Services Research- Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force

    Sep 1, 2018, 00:00

  • Economic Performance and Health Expenditures- Development Of Governmental Health Insurance Expenditures in Hungary Between 2005-2014

    Sep 1, 2018, 00:00

  • Cost-Effectiveness of Insulin Glargine/Lixisenatide Titratable Fixed-Ratio Combination for Patients with Basal Insulin-Treated Type 2 Diabetes in South Korea

    Sep 1, 2018, 00:00

  • Reporting Quality of Drug Safety Systematic Reviews- A Cross-Sectional Study

    Sep 1, 2018, 00:00

  • A Retrospective, Longitudinal Study to Investigate the Change of Blood Pressure Levels and Pharmaceutical Intervention Using A Japanese Healthcare Checkup Database

    Sep 1, 2018, 00:00

  • Cost-Effectiveness Of Percutaneous Coronary Intervention For Stable Angina In Japan

    Sep 1, 2018, 00:00

  • Utilization of Patient-Reported Outcomes in Asian Trial Literature

    Sep 1, 2018, 00:00

  • Analysis of Factors Associated With Health Care Costs For Patients With Heart Failure In Thailand- A Regression-Based Approach

    Sep 1, 2018, 00:00

  • Economic Burden of Lung Cancer Attributable to Smoking In China in 2015

    Sep 1, 2018, 00:00

  • Economics Evaluation Use Of Out-Patient Prescription Data in Pharmacloud System to The National Health Insurance Program of Taiwan in Local Community

    Sep 1, 2018, 00:00

  • Uptake of Discrete Choice Experiments in Healthcare in Southeast Asia- A Systematic Review

    Sep 1, 2018, 00:00

  • Impact of Sofosbuvir-Based Regimens for Chronic Hepatitis C Infection- A Work Productivity Model from Mainland China

    Sep 1, 2018, 00:00

  • Influence Of Self-Perceived Risk, Motivators And Barriers On Cardiovascular Health Among Young And Middle-Aged Adults In Hong Kong

    Sep 1, 2018, 00:00

  • Use of Patient Assistance Programs (Paps) to Increase Access to Innovative Drugs in Thailand. Current Situations and Prospects

    Sep 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56 (current)
  • 57
  • 58
  • 59
  • 60
  • »